Cargando…
CXCR3/CCR5 pathways in metastatic melanoma patients treated with adoptive therapy and interleukin-2
BACKGROUND: Adoptive therapy with tumour-infiltrating lymphocytes (TILs) induces durable complete responses (CR) in ∼20% of patients with metastatic melanoma. The recruitment of T cells through CXCR3/CCR5 chemokine ligands is critical for immune-mediated rejection. We postulated that polymorphisms a...
Autores principales: | Bedognetti, D, Spivey, T L, Zhao, Y, Uccellini, L, Tomei, S, Dudley, M E, Ascierto, M L, De Giorgi, V, Liu, Q, Delogu, L G, Sommariva, M, Sertoli, M R, Simon, R, Wang, E, Rosenberg, S A, Marincola, F M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3817317/ https://www.ncbi.nlm.nih.gov/pubmed/24129241 http://dx.doi.org/10.1038/bjc.2013.557 |
Ejemplares similares
-
Gene expression profiling in acute allograft rejection: challenging the immunologic constant of rejection hypothesis
por: Spivey, Tara L, et al.
Publicado: (2011) -
CXCR1 and CXCR2 enhances human melanoma tumourigenesis, growth and invasion
por: Singh, S, et al.
Publicado: (2009) -
The stable traits of melanoma genetics: an alternate approach to target discovery
por: Spivey, Tara L, et al.
Publicado: (2012) -
Interleukin-8 and its receptor CXCR2 in the tumour microenvironment promote colon cancer growth, progression and metastasis
por: Lee, Y S, et al.
Publicado: (2012) -
IRF-1 responsiveness to IFN-γ predicts different cancer immune phenotypes
por: Murtas, D, et al.
Publicado: (2013)